液体活检中的微小RNA：实现早期结直肠癌诊断简单快速检测的途径？
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis?
作者信息
Matis Serena, Poggi Alessandro, Benelli Roberto
机构信息
SSD Oncologia Molecolare e Angiogenesi, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
出版信息
Cancers (Basel). 2023 Jan 28;15(3):797. doi: 10.3390/cancers15030797.
Abstract
About 15% of colorectal cancers (CRCs) are diagnosed as advanced, metastatic stage IV, a patient condition with an average survival of 2 [...].
摘要
约15%的结直肠癌（CRC）被诊断为晚期转移性IV期，这种患者情况的平均生存期为2 [...]。
相似文献
1
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis?液体活检中的微小RNA：实现早期结直肠癌诊断简单快速检测的途径？
Cancers (Basel). 2023 Jan 28;15(3):797. doi: 10.3390/cancers15030797.
2
Relationship between COX-2 expression and clinicopathological features of colorectal cancers.环氧化酶-2（COX-2）表达与结直肠癌临床病理特征之间的关系。
Chin Med J (Engl). 2004 Aug;117(8):1151-4.
3
Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.结直肠癌中肿瘤侧别的预后影响：基于 SEER 的分析。
Clin Colorectal Cancer. 2019 Mar;18(1):e104-e116. doi: 10.1016/j.clcc.2018.10.005. Epub 2018 Oct 27.
4
Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.结直肠癌转移与非转移的表观遗传学进化特征。
Am J Pathol. 2011 Apr;178(4):1835-46. doi: 10.1016/j.ajpath.2010.12.045. Epub 2011 Mar 4.
5
The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.microRNAs 的预后价值因患者的种族/民族和结直肠癌分期而异。
Clin Cancer Res. 2013 Jul 15;19(14):3955-65. doi: 10.1158/1078-0432.CCR-12-3302. Epub 2013 May 29.
6
Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer.转移性结直肠癌液体活检的临床视角
Front Genet. 2021 Jan 28;12:634642. doi: 10.3389/fgene.2021.634642. eCollection 2021.
7
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验：一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
8
Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.研究miR-21、miR-92a和miR-200c在早期结直肠癌中的肿瘤内异质性、表达梯度及其预测淋巴结转移的潜力。
Exp Mol Pathol. 2016 Oct;101(2):187-196. doi: 10.1016/j.yexmp.2016.08.003. Epub 2016 Aug 23.
9
Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.中国遗传性非息肉病性结直肠癌患者的临床特征及错配修复基因突变筛查
World J Gastroenterol. 2004 Sep 15;10(18):2647-51. doi: 10.3748/wjg.v10.i18.2647.
10
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.荷兰基于粪便免疫化学检测的筛查计划实施前后的结直肠癌发病率、死亡率、肿瘤特征及治疗情况：一项基于人群的研究
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):60-68. doi: 10.1016/S2468-1253(21)00368-X. Epub 2021 Nov 22.
引用本文的文献
1
Downregulation of JAM3 occurs in cholangiocarcinoma by hypermethylation: A potential molecular marker for diagnosis and prognosis.JAM3 在胆管癌中因 hypermethylation 而下调：用于诊断和预后的潜在分子标志物。
J Cell Mol Med. 2024 Jan;28(2):e18038. doi: 10.1111/jcmm.18038. Epub 2023 Dec 20.
本文引用的文献
1
The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer.液体活检分析物在结直肠癌诊断、治疗和预后中的作用。
Front Endocrinol (Lausanne). 2022 Jun 30;13:875442. doi: 10.3389/fendo.2022.875442. eCollection 2022.
2
Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance.微小RNA作为结直肠癌亚型分析和化疗耐药性液体活检生物标志物的概述
Cancer Drug Resist. 2021 Oct 26;4(4):934-945. doi: 10.20517/cdr.2021.62. eCollection 2021.
3
Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis.间充质干细胞来源的细胞外囊泡传递 microRNA-34a-5p 通过 c-MYC/DNMT3a/PTEN 轴抑制结直肠癌的发生。
Mol Neurobiol. 2022 Jan;59(1):47-60. doi: 10.1007/s12035-021-02431-9. Epub 2021 Oct 8.
4
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.REMARRY 和 PURSUIT 试验：针对血浆 RAS 野生型转移性结直肠癌患者，采用帕尼单抗联合伊立替康进行液体活检指导的抗表皮生长因子受体（EGFR）治疗的再挑战。
BMC Cancer. 2021 Jun 7;21(1):674. doi: 10.1186/s12885-021-08395-2.
5
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors.液体活检：当前趋势和未来在实体瘤临床应用中的展望。
Clin Chem Lab Med. 2021 Feb 5;59(7):1181-1200. doi: 10.1515/cclm-2020-1685. Print 2021 Jun 25.
6
miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.miR-576-5p 通过靶向 Wnt5a 介导的 Wnt/β-连环蛋白信号通路促进结直肠癌细胞上皮-间充质转化。
Mol Med Rep. 2021 Feb;23(2). doi: 10.3892/mmr.2020.11733. Epub 2020 Dec 10.
7
A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.手术时结直肠癌（CRC）患者血液中独特的微小RNA（miRNA）特征
Cancers (Basel). 2020 Aug 25;12(9):2410. doi: 10.3390/cancers12092410.
8
MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.miRNA-425-5p 的表达影响结直肠癌中的 BRAF/RAS/MAPK 通路。
Int J Med Sci. 2019 Oct 11;16(11):1480-1491. doi: 10.7150/ijms.35269. eCollection 2019.
9
Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation.结直肠癌发生过程中失调的 microRNAs：对细胞存活和凋亡调控的新认识。
J Cell Physiol. 2019 Dec;234(12):21683-21693. doi: 10.1002/jcp.28872. Epub 2019 May 26.
10
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.微小 RNA 作为结直肠癌潜在诊断和预后标志物的相关性。
Int J Mol Sci. 2018 Sep 27;19(10):2944. doi: 10.3390/ijms19102944.
Zotero 插件